These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 17953654

  • 21. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?
    Del Río P, Montiel T, Chagoya V, Massieu L.
    Neuroscience; 2007 Jun 08; 146(4):1561-70. PubMed ID: 17490821
    [Abstract] [Full Text] [Related]

  • 22. Mitochondrial complex I inhibition in cerebral cortex of immature rats following homocysteic acid-induced seizures.
    Folbergrová J, Jesina P, Drahota Z, Lisý V, Haugvicová R, Vojtísková A, Houstĕk J.
    Exp Neurol; 2007 Apr 08; 204(2):597-609. PubMed ID: 17270175
    [Abstract] [Full Text] [Related]

  • 23. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A, Sandhir R.
    Behav Brain Res; 2014 Mar 15; 261():345-55. PubMed ID: 24393741
    [Abstract] [Full Text] [Related]

  • 24. Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.
    Tantucci M, Mariucci G, Taha E, Spaccatini C, Tozzi A, Luchetti E, Calabresi P, Ambrosini MV.
    Neuroscience; 2009 Oct 20; 163(3):735-40. PubMed ID: 19580850
    [Abstract] [Full Text] [Related]

  • 25. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
    Kumar P, Kumar A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):100-8. PubMed ID: 19022325
    [Abstract] [Full Text] [Related]

  • 26. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V, Elinos-Calderón D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverrí J, Ali SF, Santamaría A.
    Behav Brain Res; 2009 May 16; 199(2):210-7. PubMed ID: 19100293
    [Abstract] [Full Text] [Related]

  • 27. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons.
    Wu CL, Hwang CS, Yang DI.
    Neurotoxicology; 2009 Jul 16; 30(4):718-26. PubMed ID: 19428112
    [Abstract] [Full Text] [Related]

  • 28. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J, Boyer C, Lévèque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L.
    Behav Brain Res; 2011 Mar 01; 217(2):369-78. PubMed ID: 21070819
    [Abstract] [Full Text] [Related]

  • 29. Chromium(VI) interaction with plant and animal mitochondrial bioenergetics: a comparative study.
    Fernandes MA, Santos MS, Alpoim MC, Madeira VM, Vicente JA.
    J Biochem Mol Toxicol; 2002 Mar 01; 16(2):53-63. PubMed ID: 11979422
    [Abstract] [Full Text] [Related]

  • 30. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P, Kumar A.
    J Med Food; 2009 Jun 01; 12(3):591-600. PubMed ID: 19627208
    [Abstract] [Full Text] [Related]

  • 31. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BV, Padi SS.
    Eur J Pharmacol; 2012 Jan 05; 674(1):33-43. PubMed ID: 22056833
    [Abstract] [Full Text] [Related]

  • 32. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease.
    Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A.
    Neurosci Lett; 2008 Apr 04; 434(3):241-6. PubMed ID: 18329171
    [Abstract] [Full Text] [Related]

  • 33. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease.
    Chakraborty J, Nthenge-Ngumbau DN, Rajamma U, Mohanakumar KP.
    Behav Brain Res; 2014 May 01; 264():91-104. PubMed ID: 24509309
    [Abstract] [Full Text] [Related]

  • 34. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
    Kumar P, Kalonia H, Kumar A.
    J Psychopharmacol; 2011 Oct 01; 25(10):1399-411. PubMed ID: 20305041
    [Abstract] [Full Text] [Related]

  • 35. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
    Kumar P, Kumar A.
    Indian J Exp Biol; 2009 Sep 01; 47(9):715-22. PubMed ID: 19957883
    [Abstract] [Full Text] [Related]

  • 36. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate.
    Storgaard J, Kornblit BT, Zimmer J, Gramsbergen JB.
    Exp Neurol; 2000 Jul 01; 164(1):227-35. PubMed ID: 10877933
    [Abstract] [Full Text] [Related]

  • 37. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 01; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

  • 38. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E.
    Neurosci Lett; 2007 Oct 02; 425(3):167-72. PubMed ID: 17868993
    [Abstract] [Full Text] [Related]

  • 39. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.
    Túnez I, Montilla P, Del Carmen Muñoz M, Feijóo M, Salcedo M.
    J Pineal Res; 2004 Nov 02; 37(4):252-6. PubMed ID: 15485551
    [Abstract] [Full Text] [Related]

  • 40. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats.
    Kumar P, Kalonia H, Kumar A.
    J Asian Nat Prod Res; 2009 Nov 02; 11(5):439-50. PubMed ID: 19504387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.